Header

Monalisa Dermal Filler(Pd No. : 3076684)

(Updated : Jan/02/2017)
product information
Model Nm MONALISA, MONALISA Lidocaine
HS CODE 330499
M.O.Q
Ceritification CE
Keywords filler, HA filler, hyaluronic acid filler, dermal filler, cross link, juvederm, restylane
Seller ID genoss21
  • SHARE


[Company Introduction]


Since its establishment in 2004, GENOSS has put enormous efforts to become the worlds leading medical device company. The primary mission set forth by GENOSS is to focus on delivering treatment solutions and promoting the well-being of its consumers and patients. GENOSS strives to prepare for a big leap forward into the endless competition of the worlds biotechnology market through its technical innovation.

With a considerable portion of sales being spent on Research & Development, and supported by a group of immensely experienced and talented R&D professionals, GENOSS has demonstrated a strong commitment to R&D and to manufacture products with world-beating quality. In addition, GENOSS strictly fulfills and complies with the international quality regulations, including KGMP, ISO 13485 and ISO 9001. Furthermore, the CE mark and the FDA approval on each product confirms its conformity with all of the legal requirements.


VISION

Our vision is to be the world’s best medical device company through creating the best products and service to contribute the development of human society as a representative of Korean medical device companies.




2016

Jan KFDA for Drug Eluting Coronary Stent

Jan CE for PTA(OTW) Balloon Catheter


2015

Dec KFDA for Y connector
Nov KFDA for Orthopedic OSTEON III
Oct KFDA for Porcine Collagen Layer I
Oct KFDA for Collagen Membrane - P
Sep KFDA for Porcine Collagen Layer II
Jun KFDA for PTA(OTW) Balloon Catheter
Jun CFDA for OSTEON II
May KFDA for OSTEON III
May CE for MONALISA Filler
Mar KFDA for Collagen Graft
Feb KFDA for Osteon II Lumbar Cage
Jan KFDA for Extractor Aspiration Catheter


2014

Jul CFDA for Collagen Membrane
Jun TFDA for OSTEON
May KFDA for MONALISA Filler
Apr KFDA for Chitosan dressing
Mar CE for Ti Plate & Screw
Mar CE for Integral Cervical Cage
Feb CE for Bare Metal Coronary Stent


2013

Dec CE for Orthopedic OSTEON II
Dec CE for NC PTCA Balloon Catheter
Dec CE for Lumbar Pedicle Screw
Oct CE for Sinus Elevator
Aug CE for Polymer Guide
Jul CE for Ti Window Lumbar Cage
May KFDA for Lumber Pedicle screw
Apr KFDA for iCT Injection SE
Mar KFDA for Polymer Guide
Jan KFDA for Ti window Lumbar cage


2012
Nov KFDA for Cervical Plate
Nov KFDA for Maxillofacial Screw
Oct KFDA for Maxillofacial Plate
Sep CE for GENOSS Inflator
Jun KFDA for NC PTCA Balloon Catheter
May KFDA for Inflator
May KFDA for OSTEON II Collagen
May CE for OSTEON II
Apr KFDA for Sinus Balloon
Mar CE for PTCA Balloon Catheter
Mar KFDA for HA Collagen Membrane
Feb KFDA for Bare Metal Coronary Stent
Jan FDA for OSTEON II

2011

Dec KFDA for Orthopedic OSTEON II
Jun KFDA for OSTEON Collagen
May FDA for Collagen Membrane
Mar KFDA for OSTEON II
Mar KFDA for PEEK OSTEON Lumbar


2010

Sep KFDA for PEEK OSTEON Cervical
May KFDA for Collagen membrane


[Product Description]


1. Volume Effect and Retention
- The uniform sized hyaluronic acid particles with optimal viscoelasticity can maintain a long-lasting volume.


2. Safe to Use on Patients
- MONALISA is safe to use on patients due to low level of endotoxin and essentially no BDDE residue.


3. Easy Procedural Operation
-The ergonomically-designed rod and grip allow the even distribution of pressure during injection to enable an accurate and safe treatment for both the clinician and the patient.


4. Highly Pure Hyaluronic Acid
- GENOSS implements a strict quality control system through direct involvement in the entire production process from the base material of hyaluronic acid to the final product.


5. Global Standard Quality Control

-To guarantee the quality of MONALISA, GENOSS strictly ful lls and complies with the international quality regulations, including KGMP, ISO 13485 and ISO 9001.



Thin - wall Needle

-Thin-wall needle enables smooth injection which reduces patient's discomfort during the procedure




Ergonomic Design

Ergonomically-designed grips enable an accurate, convenient and safe treatment.





Safe to Use on Patients

The risk of allergic reaction, edema and other adverse side e ects were minimized by significantly reducing the BDDE (chemical agent used to cross-link hyaluronic acid) to the point where it is undetectable.

 

 

 

Volume Maintenance

Hy-BRID technology enables the production of highly dense and uniform particles in MONALISA.

The volume is maintained for at least 6 months before the dissolution process begins.

 

 

Highly Pure Hyaluronic Acid

GENOSS implements a strict quality control system through direct involvement in the entire production process from the base material of hyaluronic acid to the final product.

 

 

Viscoelasticity with the Optimal Ratio

The application of the Hy-BRID technology allows the MONALISA to achieve the ideal viscoelasticity for greater volume and durability compared to current competitors.

 

 

Clinical Cases


 

 

 

[Product Features]


*MONALISA(Hyaluronic Acid Dermal Filler)

MONALISA is a hyaluronic acid dermal filler which keeps application site superiorly volumizing for a long period of time following initial treatment and naturally broken down within the skin over time.



*MONALISA Lidocaine(Hyaluronic Acid Dermal Filler with Lidocaine)

MONALISA lidocaine contains non-animal hyaluronic acid with the addition of lidocaine, local anaesthetic to provide more comfort both during and after injection






 


YouTube PLAY

Company Information

company information
Contact Person Jamie Lee
Company GENOSS CO.,LTD
Address Gyeonggi R&DB Center 1F, 105, Gwanggyo-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do
Homepage www.genoss.com , http://seller.buykorea.org/genoss--EC079390
Tel 07070987569 Fax 0318885136
Biz. Type Est. Year
Employees Annual Export USD 0~1 mn
Related Business Event List
2017 GBMP Public Procurement Plaza 2017-03-16 ~ 2017-03-17
GBMP 2017 [Medical Devices] 2017-03-16 ~ 2017-03-17
2017 k-beauty expo 2017-10-11 ~ 2017-10-14
Global Beauty Business plaza 2017-10-12 ~ 2017-10-13
Healthcare Project Plaza 2017 2017-09-27 ~ 2017-09-28
Consumer Goods Showcase Korea 2018 2018-06-04 ~ 2018-06-05
Consumer Goods Showcase Korea 2018 2018-06-04 ~ 2018-06-05
Florida International Medical Expo 2018 2018-07-17 ~ 2018-07-19
Go to the top of the page
Loading...